ANDA 88557, held by Hikma. Chlorothiazide; Reserpine.
As of Nov 16, 2026, ANDA 88557 (Chlorothiazide And Reserpine), held by Hikma, was first approved by FDA on Dec 22, 1983, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 22, 1983 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Chlorothiazide And Reserpine250MG;0.125MG ยท tablet;oral | Chlorothiazide; Reserpine | Discontinued |
| Sep 20, 1990 | Supplement 9Manufacturing | Approved | None posted |
| Mar 17, 1989 | Supplement 7Labeling | Approved | None posted |
| Mar 17, 1989 | Supplement 11Labeling | Approved | None posted |
| Dec 22, 1983 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters